Skip to main content
Clinical Trials/CTRI/2024/01/061976
CTRI/2024/01/061976
Not yet recruiting
未知

A cross sectional observational study on skin tissue expression of Interleukin 17 in patients of dermatophytosis

GCSMCH&RC0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
GCSMCH&RC
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
GCSMCH&RC

Eligibility Criteria

Inclusion Criteria

  • all patients with clinically diagnosed and confirmed with KOH smear examination for tinea/ dermatophytic infection with age 18\-60 years who are willing to sign informed consent form.

Exclusion Criteria

  • A.Patients who are not willing to sign informed consent form.
  • B.Patients with age less than 18 years and more than 60 years.
  • C.Pregnant and lactating mothers.
  • D.Patients with diseases enlisted in point E\&F which may interfere with expression of IL\-17 in tissue.
  • E.Cutaneous disorders like\- acne, hidradenitis suppurativa, psoriasis, alopecia areata, vitiligo, autoimmune bullous diseases
  • F.Systemic diseases like\- multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus, asthma, Behcet’s disease, hyper IgE syndrome, systemic sclerosis
  • G.Preexisting Cardiovascular, pulmonary, hepatic, renal, hematological, gastrointestinal,endocrine, immunologic, musculoskeletal, neurological, or psychiatric disease.
  • H.Major surgical or medical illness in last 4 weeks before screening, Any concomitant medication for purpose other than dermatophytosis management at presentation or within last 4 weeks before screening.
  • I.Any concomitant intake of herbal, homeopathic or other alternative therapy at presentation or within last 4 weeks before screening.
  • J.Alcohol dependence, alcohol abuse or drug abuse within the past year.

Outcomes

Primary Outcomes

Not specified

Similar Trials